Immuron IMRN
NASDAQ IMRN
$0.97 -0.05 (-4.90%)
At close: Oct 21, 2026 · 4:00 PM EDT

Immuron (IMRN) Notes Payables (2017 - 2019)

Updated

Immuron's Notes Payables came in at $98,120 for FY2019 (year ended Dec 31, 2019).

Analysis

Immuron (IMRN) Notes Payables (2017 - 2019) Analysis & Trends

  • Per Business Quant, earlier fiscal years put Notes Payables at $105,466 in FY2017.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn
10 Immuron 7.32 Mn -9.83 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2019 98,120.00
Jun 30, 2017 107,488.47
API Access

Immuron Notes Payables API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=notes-payables&ticker=IMRN&period=max&api_key=YOUR_API_KEY